Understanding antibody-dependent enhancement in dengue: Are afucosylated IgG1s a concern?

• Andrew Teo ,

  * E-mail: andrewcc.teo@ntu.edu.sg (AT); linlin.chua@taylors.edu.my (CLLC)

  Affiliations Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore, Singapore, National Centre for Infectious Diseases, Singapore, Singapore, Department of Medicine, The Doherty Institute, University of Melbourne, Melbourne, Australia

  https://orcid.org/0000-0002-4520-2701

  ⨯
• Hao Dong Tan,

  Affiliation School of Biosciences, Faculty of Health and Medicine Sciences, Taylor’s University, Subang Jaya, Malaysia

  ⨯
• Thomas Loy,

  Affiliation A*STAR Infectious Diseases Labs, Agency for Science, Technology and Research (A*STAR), Singapore, Singapore

  ⨯
• Po Ying Chia,

  Affiliations Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore, Singapore, National Centre for Infectious Diseases, Singapore, Singapore, Department of Infectious Diseases, Tan Tock Seng Hospital, Singapore, Singapore

  ⨯
• Caroline Lin Lin Chua

  * E-mail: andrewcc.teo@ntu.edu.sg (AT); linlin.chua@taylors.edu.my (CLLC)

  Affiliation School of Biosciences, Faculty of Health and Medicine Sciences, Taylor’s University, Subang Jaya, Malaysia

  ⨯